Aeglea BioTherapeutics OverviewAeglea BioTherapeutics Net Income
Profitability analysis for AGLE.
Quarterly Net Income
-$69.00M
↓ 54.12% YoY
As of Mar 2026
Annual Net Income (TTM)
-$179.44M
↓ 110.99% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...